CRP and hypertensive disorder: In this model, older age (OR: 1.04, 95% CI: 1.02–1.07), increased BMI (OR: 1.08, 95% CI: 1.02–1.15), hypertension (OR: 1.89, 95% CI: 1.15–3.10), higher CRP level (OR: 1.16, 95% CI: 1.05–1.29), presence of mixed inflammatory infiltrate (OR: 2.18, 95% CI: 1.14–4.19), advanced T stage (T4 vs. T1; OR: 2.12, 95% CI: 1.03–4.35), lymph node involvement (N2 vs. N0; OR: 2.05, 95% CI: 1.09–3.85), and metastasis (M1; OR: 2.65, 95% CI: 1.26–5.58) significantly predicted cardiovascular disease risk.